SEOUL, April 6 (Yonhap) -- South Korean shares opened higher Monday amid hopes of a potential treatment for the new coronavirus that has infected more than 1.2 million people around the world.
The benchmark Korea Composite Stock Price Index (KOSPI) rose 20.56 points, or 1.19 percent, to 1,746.00 in the first 15 minutes of trading.
Seo Sang-young, a researcher at Kiwoom Securities Co., said the main index received a boost amid positive news about Gilead Sciences' remdesivir against COVID-19.
Daniel O'Day, chairman and CEO of Gilead Sciences, said Saturday that multiple clinical trials for remdesivir are under way, involving thousands of patients with COVID-19 across the world.
The company has expanded production and increased supply after it learned that remdesivir may have the potential to treat the novel coronavirus.
In South Korea, the novel coronavirus has killed 183 people, mostly elderly patients with underlying illnesses. Its virus cases topped 10,000.
Most large-cap stocks rose across the board.
Market bellwether Samsung Electronics Co. rose 0.85 percent, No. 2 chipmaker SK hynix Inc. was up 1.13 percent, and top carmaker Hyundai Motor Co. gained 0.23 percent.
The local currency was trading at 1,237.85 won against the U.S. dollar, down 6.95 won from the previous session's close.
BTS member Jimin's 'hanbok' suit up for auction
BTS enters Billboard Hot 100 with new Japanese single
BTS to stream concerts in weekend Bang Bang Con event
(LEAD) Seoul mayor pushes for introduction of self-testing kits, extending hours for small businesses
BLACKPINK amasses 60 mln subscribers on YouTube: agency
Number of peak concurrent viewers on BTS online event surpasses 2.7 mln: agency
(LEAD) New virus cases in 600s for 4th day as sporadic infections continue
S. Korea to start vaccinations of care workers, airline crews
Vaccine supply glitch threatening to take inoculation scheme off track
(LEAD) Kerry: Japan's coordination with IAEA is 'key' to ensuring safety in Fukushima water release